Print Friendly, PDF & Email

ALZ Survivor Sally Uses The Bredesen ProtocolTM

Sally is an ALZ survivor who uses The Bredesen ProtocolTM.  Consequently, she has her life back!  Due to staying on her customized  program, Sally continues to be an ALZ survivor.   Sally isn’t the only one to reverse her cognitive decline. There are hundreds of people on the Protocol who have done the same and now have their lives back.  These ALZ survivors continue to follow their individualized  programs.  However, those who fall off their programs notice a decline in their thought processes.

These are people who were diagnosed with Alzheimer’s and in some cases told to begin closing down their businesses. Yet, once they sought a Bredesen trained physician or health care practitioner, their decline halted and their cognition began to improve. Furthermore, these patients were not only able to return to work, but in some cases expand their businesses, travel the world, or learn a new language!

The Proper Evaluation & Testing Developed by Dr. Dale E. Bredesen

After 30 years of research, Dr. Dale E. Bredesen, neurologist and neuroscientist, developed The Bredesen ProtocolTM.  Chiefly, his Protocol works because the physician isn’t treating the patient blindly.  The proper evaluation and testing, called a CognoscopyTM, includes these simple tests:

– blood tests (chemical, hormonal, metabolic and toxicity tests)
– genetic tests
– a simple online cognitive assessment
– a brain MRI (if needed)

From the CognoscopyTM, a computerized program develops an assessment and personalized program for the patient.  Then, whatever threats are revealed through testing, they are addressed.  The Protocol also focuses largely on diet, fasting, exercise, sleep, stress reduction, and other lifestyle factors.

Update 4/24/19:  Sally continues to do well and is now four years into The Bredesen ProtocolTM.  In addition, Sally scored a perfect 30 out of 30 on the MoCA (Montreal Cognitive Assessment) Test for Dementia.  Go Sally!  More about Sally and other ALZ survivors using The Bredesen ProtocolTM.

Survivors Exist in Growing Numbers
What is The Bredesen ProtocolTM
?

ALZsurvivor [home] > ALZ Survivor Sally Uses Bredesen Protocol

COVID-19 & ALZ connection (mask)

The TRUTH About Alzheimer’s Drugs . . .

Share It!

See more memes here.
Share 'em - help save lives!

Glossary

ALZ
abbreviation for Alzheimer’s Disease
Alzheimer’s Disease
a type of dementia and a progressive disease of the brain that slowly causes impairment in memory and cognitive function. Alzheimer’s disease happens when the brain tries to protect itself from three metabolic and toxic threats:


1 - Inflammation (from infection, diet or other causes)
2 - Decline and shortage of supportive nutrients, hormones and other brain-supporting molecules
3 - Toxic substances such as metals or biotoxins (poisons produced by microbes such as molds)

The protective response causes APP (Amyloid Precursor Protein, the long molecule that protrudes from neurons) to be cut into four fragments, including amyloid-beta, that downsize the neural network and eventually destroy synapses and neurons. When the APP molecule is cut into those four pieces, it is not cut into the two pieces that nourish and maintain synapses.

Alzheimer's disease is a state of the brain in which there is an imbalance between the reorganization of synapses that have outlived their usefulness (and which the brain can stand to lose - healthy destruction) and the maintenance or creation of existing and new synapses (which the brain needs to sustain old memories and form new ones, as well as perform other cognitive functions). That imbalance  comes from too many  of the synapse- and neuron-destroying quartet  of molecules snipped from APP and too few  of the synapse- and neuron-sustaining duo  of molecules snipped from APP.

ApoE4
abbreviation for apolipoprotein E, a gene variant (allele) which is a protein that carries lipids – i.e. fats. Carrying one ApoE4 (inherited from one parent) increases your lifetime risk of Alzheimer’s to 30 percent. Carrying two copies (from both parents) increases it to 50 to 90 percent. That compares to a risk of only about 9 percent in those who carry zero copies of this allele.
APP
abbreviation for Amyloid Precursor Protein, the long molecule that protrudes from neurons

CognoscopyTM
metabolic and genetic testing that identifies cognitive decline or what may be putting you at risk for it
Dementia
umbrella term for a group of symptoms (a syndrome) without a definitive diagnosis. Dementia is a group of symptoms that affect mental cognitive tasks such as memory and reasoning. (Alzheimer’s Disease is the most common type of dementia.)
Early Alzheimer’s Disease
an early onset of Alzheimer’s Disease and uncommon form of dementia that typically affects those under the age of 65
Functional Medicine
a systems biology–based approach that focuses on identifying and addressing the root cause of disease
Heterozygous
carrying 1 copy of the ApoE4 genetic variant
Homozygous
carrying 2 copies of the ApoE4 genetic variant
Integrative Medicine
healing-oriented medicine that takes account of the whole person, including all aspects of lifestyle. It emphasizes the therapeutic relationship between practitioner and patient, is informed by evidence, and makes use of all appropriate therapies.
Ketoflex 12/3
anti-Alzheimer’s diet to include at least 12 hours of fasting, with the first 3 hours of that fast starting after dinner. It is largely plant based, but flexible as it does allow for small amounts of meat or fish.
MCI
Mild Cognitive Impairment
MCT oil
an abbreviation for medium chain triglyceride (a saturated fat) which is found in coconut oil.  Alzheimer's impairs the brain's ability to use sugar.  An MCT ketogenic diet offers an alternative energy source:  ketones.  This allows brain cells to survive better, blocking a receptor in the brain that causes memory loss.
SCI
Subjective Cognitive Impairment – a precursor to MCI (Mild Cognitive Impairment)
The Bredesen ProtocolTM
treatment program developed by Dr. Dale E. Bredesen to prevent and reverse cognitive decline (also known as The ReCODE ProtocolTM)
The ReCODE ProtocolTM
treatment program developed by Dr. Dale E. Bredesen to prevent and reverse cognitive decline (also known as The Bredesen ProtocolTM)
The ReCODE Report
computer generated report as a result of metabolic and genetic testing (CognoscopyTM)
The ReVERSE Program
customized  treatment program to reverse cognitive decline. This program starts with a ReCODE Report (a computer generated report as a result of metabolic and genetic testing called a CognoscopyTM)

Send this to a friend